Improving asthma control

GlaxoSmithKline announces extended asthma control therapy indication for children above a year of age.

GLAXOSMITHKLINE Pharmaceutical (GSK) recently announced an extended indication for fluticasone propionate 50mcg, a pressurised metered-dose inhaler which has a marked anti-inflammatory effect in the lungs.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Health , asthma , GlaxoSmithKline , child care , children's health , inhaler

Next In Health
Pros and cons of drinking your ‘meal’�
When you fracture your foot�
Neurosurgeons can operate on more than the brain
Helping our children feel confident�
Angina: The pain in the chest that forewarns a heart attack
Understanding GLP-1 drugs, those popular weight-loss medications
From vision to action: Reset-ting Malaysia's healthcare system
Beware of instant coffee with ‘extra power’��
Ladies, prepare early for those potential extra kilos�
Keeping our children safe on the road

Trending in Lifestyle

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.